Anticancer Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: A90D5CFB8DF8EN
Market Monitor Global

Abstracts

Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.

This report contains market size and forecasts of Anticancer Drug in Global, including the following market information:

Global Anticancer Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anticancer Drug market was valued at 98080 million in 2021 and is projected to reach US$ 151540 million by 2028, at a CAGR of 6.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Targeted Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anticancer Drug include Roche, Celgene, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceuticals, Bayer and GlaxoSmithKline. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anticancer Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anticancer Drug Market Segment Percentages, by Type, 2021 (%)

• Targeted Drugs
• Cytotoxic Drugs
• Hormonal Drugs
• Others

Global Anticancer Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anticancer Drug Market Segment Percentages, by Application, 2021 (%)

• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Hormonal Therapy
• Others

Global Anticancer Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anticancer Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anticancer Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anticancer Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Celgene
• Pfizer
• Bristol-Myers Squibb
• Novartis
• AstraZeneca
• Teva Pharmaceuticals
• Bayer
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anticancer Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anticancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTICANCER DRUG OVERALL MARKET SIZE

2.1 Global Anticancer Drug Market Size: 2021 VS 2028
2.2 Global Anticancer Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anticancer Drug Players in Global Market
3.2 Top Global Anticancer Drug Companies Ranked by Revenue
3.3 Global Anticancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Anticancer Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anticancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticancer Drug Players in Global Market
  3.6.1 List of Global Tier 1 Anticancer Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anticancer Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anticancer Drug Market Size Markets, 2021 & 2028
  4.1.2 Targeted Drugs
  4.1.3 Cytotoxic Drugs
  4.1.4 Hormonal Drugs
  4.1.5 Others
4.2 By Type - Global Anticancer Drug Revenue & Forecasts
  4.2.1 By Type - Global Anticancer Drug Revenue, 2017-2022
  4.2.2 By Type - Global Anticancer Drug Revenue, 2023-2028
  4.2.3 By Type - Global Anticancer Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anticancer Drug Market Size, 2021 & 2028
  5.1.2 Immunotherapy
  5.1.3 Targeted Therapy
  5.1.4 Chemotherapy
  5.1.5 Hormonal Therapy
  5.1.6 Others
5.2 By Application - Global Anticancer Drug Revenue & Forecasts
  5.2.1 By Application - Global Anticancer Drug Revenue, 2017-2022
  5.2.2 By Application - Global Anticancer Drug Revenue, 2023-2028
  5.2.3 By Application - Global Anticancer Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anticancer Drug Market Size, 2021 & 2028
6.2 By Region - Global Anticancer Drug Revenue & Forecasts
  6.2.1 By Region - Global Anticancer Drug Revenue, 2017-2022
  6.2.2 By Region - Global Anticancer Drug Revenue, 2023-2028
  6.2.3 By Region - Global Anticancer Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anticancer Drug Revenue, 2017-2028
  6.3.2 US Anticancer Drug Market Size, 2017-2028
  6.3.3 Canada Anticancer Drug Market Size, 2017-2028
  6.3.4 Mexico Anticancer Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anticancer Drug Revenue, 2017-2028
  6.4.2 Germany Anticancer Drug Market Size, 2017-2028
  6.4.3 France Anticancer Drug Market Size, 2017-2028
  6.4.4 U.K. Anticancer Drug Market Size, 2017-2028
  6.4.5 Italy Anticancer Drug Market Size, 2017-2028
  6.4.6 Russia Anticancer Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Anticancer Drug Market Size, 2017-2028
  6.4.8 Benelux Anticancer Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anticancer Drug Revenue, 2017-2028
  6.5.2 China Anticancer Drug Market Size, 2017-2028
  6.5.3 Japan Anticancer Drug Market Size, 2017-2028
  6.5.4 South Korea Anticancer Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Anticancer Drug Market Size, 2017-2028
  6.5.6 India Anticancer Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anticancer Drug Revenue, 2017-2028
  6.6.2 Brazil Anticancer Drug Market Size, 2017-2028
  6.6.3 Argentina Anticancer Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anticancer Drug Revenue, 2017-2028
  6.7.2 Turkey Anticancer Drug Market Size, 2017-2028
  6.7.3 Israel Anticancer Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Anticancer Drug Market Size, 2017-2028
  6.7.5 UAE Anticancer Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Anticancer Drug Major Product Offerings
  7.1.4 Roche Anticancer Drug Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene Anticancer Drug Major Product Offerings
  7.2.4 Celgene Anticancer Drug Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Anticancer Drug Major Product Offerings
  7.3.4 Pfizer Anticancer Drug Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Anticancer Drug Major Product Offerings
  7.4.4 Bristol-Myers Squibb Anticancer Drug Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Anticancer Drug Major Product Offerings
  7.5.4 Novartis Anticancer Drug Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Anticancer Drug Major Product Offerings
  7.6.4 AstraZeneca Anticancer Drug Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Teva Pharmaceuticals
  7.7.1 Teva Pharmaceuticals Corporate Summary
  7.7.2 Teva Pharmaceuticals Business Overview
  7.7.3 Teva Pharmaceuticals Anticancer Drug Major Product Offerings
  7.7.4 Teva Pharmaceuticals Anticancer Drug Revenue in Global Market (2017-2022)
  7.7.5 Teva Pharmaceuticals Key News
7.8 Bayer
  7.8.1 Bayer Corporate Summary
  7.8.2 Bayer Business Overview
  7.8.3 Bayer Anticancer Drug Major Product Offerings
  7.8.4 Bayer Anticancer Drug Revenue in Global Market (2017-2022)
  7.8.5 Bayer Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline Anticancer Drug Major Product Offerings
  7.9.4 GlaxoSmithKline Anticancer Drug Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anticancer Drug Market Opportunities & Trends in Global Market
Table 2. Anticancer Drug Market Drivers in Global Market
Table 3. Anticancer Drug Market Restraints in Global Market
Table 4. Key Players of Anticancer Drug in Global Market
Table 5. Top Anticancer Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anticancer Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anticancer Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anticancer Drug Product Type
Table 9. List of Global Tier 1 Anticancer Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticancer Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anticancer Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anticancer Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anticancer Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anticancer Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anticancer Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anticancer Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anticancer Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anticancer Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anticancer Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anticancer Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anticancer Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anticancer Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anticancer Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anticancer Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anticancer Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anticancer Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anticancer Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anticancer Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anticancer Drug Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Anticancer Drug Product Offerings
Table 32. Roche Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Anticancer Drug Product Offerings
Table 35. Celgene Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Anticancer Drug Product Offerings
Table 38. Pfizer Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Anticancer Drug Product Offerings
Table 41. Bristol-Myers Squibb Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Anticancer Drug Product Offerings
Table 44. Novartis Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Anticancer Drug Product Offerings
Table 47. AstraZeneca Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceuticals Corporate Summary
Table 49. Teva Pharmaceuticals Anticancer Drug Product Offerings
Table 50. Teva Pharmaceuticals Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Anticancer Drug Product Offerings
Table 53. Bayer Anticancer Drug Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Anticancer Drug Product Offerings
Table 56. GlaxoSmithKline Anticancer Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anticancer Drug Segment by Type in 2021
Figure 2. Anticancer Drug Segment by Application in 2021
Figure 3. Global Anticancer Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anticancer Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anticancer Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anticancer Drug Revenue in 2021
Figure 8. By Type - Global Anticancer Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anticancer Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anticancer Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anticancer Drug Revenue Market Share, 2017-2028
Figure 12. US Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anticancer Drug Revenue Market Share, 2017-2028
Figure 16. Germany Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anticancer Drug Revenue Market Share, 2017-2028
Figure 24. China Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anticancer Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anticancer Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anticancer Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceuticals Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline Anticancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)